Clinical Trial Update: Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating thalidomide for idiopathic pulmonary fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Johns Hopkins University | Conditions: Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 | Status: COMPLETED